Abstract
The immunogenicity and safety of a new Haemophilus influenzae type b conjugate vaccine, PRP-T, was studied in 107 infants from the Oxford district. The vaccine was given concurrently with diphtheria, pertussis, tetanus, and polio vaccines at 2, 3, and 4 months of age. Symptoms after immunisation were recorded by a parent. Sera were obtained before the first immunisation and at 5 months of age and the antibodies were measured by both radioimmunoassay and enzyme linked immunosorbent assay (ELISA). No serious adverse reactions were observed and there was no increase in the incidence of expected minor side effects. By radioimmunoassay, the geometric mean titre of serum anticapsular antibody increased from 0.09 micrograms/ml before immunisation to 5.01 micrograms/ml after three immunisations. Ninety eight per cent of children had antibody concentrations consistent with protection (greater than or equal to 0.15 micrograms/ml). IgG antibody concentrations measured by ELISA correlated well with total antibody concentrations measured by radioimmunoassay (r = 0.864). These results provide encouragement that routine immunisation against H influenzae type b at 2, 3, and 4 months of age, could prevent most cases of disease in children in the UK.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Claesson B. A., Schneerson R., Robbins J. B., Johansson J., Lagergard T., Taranger J., Bryla D., Levi L., Cramton T., Trollfors B. Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate. J Pediatr. 1989 Jan;114(1):97–100. doi: 10.1016/s0022-3476(89)80611-0. [DOI] [PubMed] [Google Scholar]
- FARR R. S. A quantitative immunochemical measure of the primary interaction between I BSA and antibody. J Infect Dis. 1958 Nov-Dec;103(3):239–262. doi: 10.1093/infdis/103.3.239. [DOI] [PubMed] [Google Scholar]
- Gray B. M. ELISA methodology for polysaccharide antigens: protein coupling of polysaccharides for adsorption to plastic tubes. J Immunol Methods. 1979;28(1-2):187–192. doi: 10.1016/0022-1759(79)90340-5. [DOI] [PubMed] [Google Scholar]
- Peltola H., Käyhty H., Virtanen M., Mäkelä P. H. Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. N Engl J Med. 1984 Jun 14;310(24):1561–1566. doi: 10.1056/NEJM198406143102404. [DOI] [PubMed] [Google Scholar]
- Phipps D. C., West J., Eby R., Koster M., Madore D. V., Quataert S. A. An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. J Immunol Methods. 1990 Dec 31;135(1-2):121–128. doi: 10.1016/0022-1759(90)90264-v. [DOI] [PubMed] [Google Scholar]
- Pollock T. M., Miller E., Mortimer J. Y., Smith G. Symptoms after primary immunisation with DTP and with DT vaccine. Lancet. 1984 Jul 21;2(8395):146–149. doi: 10.1016/s0140-6736(84)91057-2. [DOI] [PubMed] [Google Scholar]
- Santosham M., Reid R., Ambrosino D. M., Wolff M. C., Almeido-Hill J., Priehs C., Aspery K. M., Garrett S., Croll L., Foster S. Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin. N Engl J Med. 1987 Oct 8;317(15):923–929. doi: 10.1056/NEJM198710083171503. [DOI] [PubMed] [Google Scholar]
- Tudor-Williams G., Frankland J., Isaacs D., Mayon-White R. T., MacFarlane J. A., Rees D. G., Moxon E. R. Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom. Arch Dis Child. 1989 Apr;64(4):520–524. doi: 10.1136/adc.64.4.520. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tudor-Williams G., Frankland J., Isaacs D., Mayon-White R. T., MacFarlane J. A., Slack M. P., Anderson E., Rees D. G., Moxon E. R. Haemophilus influenzae type b disease in the Oxford region. Arch Dis Child. 1989 Apr;64(4):517–519. doi: 10.1136/adc.64.4.517. [DOI] [PMC free article] [PubMed] [Google Scholar]